Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 13Esophageal Neoplasms 7Rectal Neoplasms 6Colorectal Neoplasms 6Adenocarcinoma Of Esophagus 6Nasopharyngeal Carcinoma 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Polyps 3Lung Neoplasms 3Precancerous Conditions 2Pathologic Complete Response 2Hyperplasia 2Gastroesophageal Reflux 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Adenomatous Polyposis Coli 2Adenocarcinoma 2Urogenital Neoplasms 1Upper Tract Urothelial Carcinoma 1Thyroid Neoplasms 1Stomach Ulcer 1Stomach Diseases 1Recurrence 1Polyposis, Gastric 1Ovarian Neoplasms 1Nasopharyngeal Neoplasms 1Metaplasia 1

Interventions

Cyclophosphamide 151Dexamethasone 140Rituximab 83fludarabine 78Cytarabine 69Lenalidomide 68Bortezomib 63fludarabine phosphate 62Gemcitabine 62venetoclax 54Etoposide 53pembrolizumab 52pomalidomide 48Paclitaxel 48Cisplatin 47Carboplatin 47Peripheral Blood Stem Cell Transplantation 46Filgrastim 40Radiotherapy 39Calcium Dobesilate 36Busulfan 36Methotrexate 34Melphalan 34Bevacizumab 33carfilzomib 32Cyclosporine 32Azacitidine 32Mycophenolic Acid 29Vincristine 28Temozolomide 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Recurrence × Endoscopy × Clear all
NCT03183115 2023-03-03

RFA to Prevent Metachronous Squamous Neoplasia Recurrence After Complete Endoscopic Submucosal Dissection

E-DA Hospital

Phase NA Recruiting
100 enrolled
Gastrointestinal

Esophageal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡